Cargando…
Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery
BACKGROUND: For patients initially diagnosed with metastatic Her2-positive breast cancer (MHBC), we intended to construct a nomogram with risk stratification to predict prognosis and to explore the role of local surgery. METHODS: We retrieved data from the Surveillance, Epidemiology, and End Results...
Autores principales: | Lin, Hong, Wu, Yanxuan, Liang, Guoxi, Chen, Liming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654787/ https://www.ncbi.nlm.nih.gov/pubmed/33170907 http://dx.doi.org/10.1371/journal.pone.0242155 |
Ejemplares similares
-
Exploring the Prognosis of Breast Cancer with Synchronous Distant Nonregional Lymph Node Metastasis and Establishing a Predictive Model: A Population-Based Study
por: Lin, Hong, et al.
Publicado: (2022) -
Prognostic and Diagnostic Significance of circRNA Expression in Esophageal Cancer: A Meta-analysis
por: Lin, Hong, et al.
Publicado: (2020) -
The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review
por: Mendes, Diogo, et al.
Publicado: (2015) -
A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
por: Li, Huiping, et al.
Publicado: (2018) -
Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus
por: Duan, Fangfang, et al.
Publicado: (2021)